Write in a clean editor, then format for Multiple Sclerosis Journal - Experimental Translational and Clinical in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Multiple Sclerosis Journal - Experimental Translational and Clinical is a peer-reviewed journal published by SAGE, covering Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Amyotrophic Lateral Sclerosis Research.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Multiple Sclerosis Journal - Experimental Translational and Clinical, 12(3), pp. 45–58.
Formats any DOI in Multiple Sclerosis Journal - Experimental Translational and Clinical style. No sign-up. |
| Publishes research in | Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Amyotrophic Lateral Sclerosis Research Polyomavirus and related diseases Systemic Sclerosis and Related Diseases |
| ISSN | 2055-2173 |
| Citation impact (2-yr) | 1.06 |
| h-index | 40 |
| i10-index | 245 |
| Total citations | 7,384 |
| Article processing charge | $2,000 |
| Open access | Yes |
| Top institutions publishing here | Cleveland Clinic |
| Journal website | us.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND: Dimethyl fumarate (DMF), a disease-modifying therapy for multiple sclerosis (MS), causes lymphopenia in a fraction of patients. The clinical significance of this is unknown. Several cases of progressive multifocal leukoencephalopathy in lymphopenic fumarate-treated patients have raised concerns about drug safety. Since lymphocytes contribute to MS pathology, lymphopenia may also be a biomarker for response…
BACKGROUND: Pain is a frequent symptom in aquaporin-4-immunoglobulin-G-positive neuromyelitis optica spectrum disorders (AQP4-IgG-pos. NMOSD). Data on pain in myelin-oligodendrocyte-glycoprotein-immunoglobulin-G autoimmunity with a clinical NMOSD phenotype (MOG-IgG-pos. NMOSD) are scarce. OBJECTIVE: The objective of this paper is to investigate pain in MOG-IgG-pos. NMOSD, AQP4-IgG-pos. NMOSD and NMOSD without AQP4/MOG-IgG detection (AQP4/MOG-IgG-neg. NMOSD). METHODS: = 6) NMOSD…
There is an obvious disconnect between evidence of benefits and rates of participation in exercise and physical activity among people living with multiple sclerosis (MS). We propose that the problem with exercise behavior in MS (i.e. lack of broad or increasing participation by people with MS despite evidence of meaningful benefits) might be ameliorated through…
Background: Patients with MS have an altered gut microbiota compared to healthy individuals, as well as elevated small intestinal permeability, which may be contributing to the development and progression of the disease. Objective: We sought to investigate if fecal microbiota transplantation was safe and tolerable in MS patients and if it could improve abnormal intestinal…
Background The association of peripapillary retinal nerve fibre layer (pRNFL) and ganglion cell-inner plexiform layer (GCIPL) thickness with neurodegeneration in multiple sclerosis (MS) is well established. The relationship of the adjoining inner nuclear layer (INL) with inflammatory disease activity is less well understood. Objective The objective of this paper is to investigate the relationship of…
